Hepatitis C
Therapeutics company expands hepatitis C collaboration with Merck
Published in Hepatitis Weekly, February 21st, 2005
The companies will continue their joint efforts to identify novel small molecule therapeutics for the treatment of hepatitis C virus infections (HCV) for an additional 12 months, through December 2005.
Under the extension, which was permitted under the terms of the existing agreement, Merck will continue to contribute drug candidates to the collaboration and fund Metabasis' efforts to apply its technologies to those candidates with the goal of producing a candidate suitable for clinical...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-02-21)
More Articles from Hepatitis Weekly
- Chronic Hepatitis C
Reports describe recent advances in chronic hepatitis c research - Diagnostics
Oral fluids expose hepatitis C virus antibody status - Diagnostics
Researchers' work adds to diagnostics body of knowledge - Drug Resistance
Tenofovir reduces hepatitis B virus load in HIV-positive patients - Hepatitis C Therapy
The non-nucleoside inhibitor HCV-371 attacks viral polymerase - Immunology
Data advance knowledge in immunology research - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
